PODD — INSULET CORP

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1145197 ·
Last close
$145.34
Market Cap
$10.08B
52W High
$354.88
52W Low
$126.40
ADV30
1,404,505
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 842,000,000 632,100,000 189,800,000 141,100,000 3,415,100,000 584,400,000 1,836,000,000
Jun 2026 801,700,000 562,600,000 129,700,000 95,000,000 3,165,100,000 534,900,000 1,742,900,000
Mar 2026 761,700,000 529,100,000 122,200,000 91,100,000 2,987,200,000 480,400,000 1,684,600,000
Dec 2025 783,800,000 568,600,000 146,300,000 101,600,000 3,190,400,000 716,100,000 1,675,100,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$509,000,000
Investing CF
$-284,600,000
Financing CF
$-394,300,000
CapEx
$-276,400,000
Dividends Paid
—
Buybacks
$-300,000,000
EPS Diluted TTM
$6.14
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$614,500,000
Inventory
$552,100,000
Receivables
$689,000,000
ST Investments
—
EBIT TTM
$608,400,000
Pretax Income TTM
$549,100,000
Interest Exp TTM
$59,300,000
Analysts
23

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,189,199,872
EBITDA
$693,299,968
Free Cash Flow
$113,512,496
Enterprise Value
$10,617,551,872
Total Cash
$584,400,000
Total Debt
$1,038,400,000
Shares Out
69,371,043
Trailing EPS
$6.12
Book Value
$22.76
ROE
28.9%
ROA
11.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 2,708,100,000 473,800,000 247,100,000 3,190,400,000 — 1,515,300,000 569,300,000
Dec 2024 2,071,600,000 308,900,000 418,300,000 3,087,700,000 1,876,100,000 1,211,600,000 430,200,000
Dec 2023 1,697,100,000 220,100,000 206,300,000 2,588,200,000 1,855,500,000 732,700,000 145,700,000
Dec 2022 1,305,300,000 37,600,000 4,600,000 2,251,100,000 1,774,700,000 476,400,000 119,000,000
Dec 2021 — — — — 1,492,500,000 — —

TTM Snapshot

Revenues TTM
$3,053,400,000
NetIncome TTM
$375,300,000
OpCashFlow TTM
—
Assets (Latest)
$3,165,100,000
Forward EPS
$7.90

Max Pain — expiry 2026-12-18

max pain strike: $150.00 · spot: $139.98 · call oi: 3,191 · put oi: 3,837
Expected Move to 2026-12-18: ±$14.35 (10.25%) — implied range $125.63 – $154.33 · ATM straddle on $140.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ALGN ALIGN TECHNOLOGY INC $11.52B $163.46 —
PEN Penumbra Inc $12.58B $319.11 —
SNN SMITH & NEPHEW PLC $12.77B $30.51 —
SNNUF SMITH & NEPHEW PLC $12.93B $15.45 —
GMED GLOBUS MEDICAL INC $7.72B $69.99 —

News headlines (Yahoo Finance, 1h cache)

Insulet downgraded, Tandem Diabetes upgraded: Wall Street's top analyst calls
2026-11-18 14:35 · Yahoo
Can Insulet Stock Jump 50%?
2026-11-16 23:20 · Yahoo
Insulet (PODD) Just Overtook the 20-Day Moving Average
2026-11-12 13:35 · Yahoo
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
2026-11-10 19:42 · Yahoo
For World Diabetes Day, Insulet Launches "Give Yourself the Freedom to" Campaign, Encouraging People with Diabetes to Prioritize Their Well-Being
2026-11-09 12:00 · Yahoo
Insulet (PODD) Stock May Be 36% Undervalued Despite $1b Buyback
2026-11-05 23:20 · Yahoo
Insulet Stock What’s Changed After Earnings Beat
2026-11-05 05:24 · Yahoo
Insulet Corp (PODD) Q3 2026 Earnings Call Highlights: Revenue Up 19%, EPS Jumps 60% and $1 ...
2026-11-05 03:06 · Yahoo
What Insulet (PODD) Said on Its Q3 Earnings Call
2026-11-04 19:14 · Yahoo
Insulet Corporation Q3 2026 Earnings Call Summary
2026-11-04 18:29 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.